Concepedia

Publication | Open Access

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

DOIFull Paper Access

65

Citations

39

References

2008

Year

Henrik Almroth, Niklas Höglund, Kurt Boman, Anders Englund, Steen M. Jensen, B Kjellman, Per Tornvall, Mårten Rosenqvist
European Heart Journal

Abstract

Atorvastatin was not statistically superior to placebo with regards to maintaining SR 30 days after CV in patients with persistent AF.

References

YearCitations

Page 1